# YS BIOPHARMA CO LTD (LSBPW)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/LSBPW/

- Reporting holders: 2
- Reported value: $3
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Ancora Advisors LLC](https://holderbook.com/funds/1446114-ancora-advisors-llc/) | $3 | 5,050 | 0.0% | 14 |
| [SkyView Investment Advisors, LLC](https://holderbook.com/funds/1848237-skyview-investment-advisors-llc/) | $0 | 12,210 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 2 | $3 |
| Q1 2026 | 1 | $18 |
| Q4 2025 | 2 | $50 |
| Q3 2025 | 2 | $32 |
| Q2 2025 | 19 | $218.6K |
| Q1 2025 | 20 | $216.3K |
| Q4 2024 | 20 | $420.5K |
| Q3 2024 | 22 | $289.2K |
| Q2 2024 | 25 | $568.4K |
| Q1 2024 | 26 | $388.4K |
| Q4 2023 | 29 | $233.4K |
| Q3 2023 | 31 | $294.6K |